From: Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan
Factor
Odds ratio (95 % CI)
P value
CDAI at baseline
0.993 (0.985–1.000)
0.0577
Colonic type
0.207 (0.035–1.230)
0.0833